News

LISCure Biosciences Embraces New Pharma Partnerships for ExoPN-101

LISCure Biosciences Embraces New Pharma Partnerships for ExoPN-101

LISCure Biosciences Develops Innovative Collaborations

LISCure Biosciences, a pioneering biotechnology firm, has recently announced its latest strides in the field of therapeutics. With a focus on next-generation solutions, LISCure is making waves in the industry by entering a new Material Transfer Agreement (MTA) with a prominent global pharmaceutical partner. This agreement is specifically for the company's proprietary blood-brain barrier (BBB) shuttle platform known as ExoPN-101.

Understanding the ExoPN-101 Platform

ExoPN-101 stands out for its ability to effectively transport a variety of therapeutic modalities directly to the brain. This includes antisense oligonucleotides (ASO), small RNA (siRNA), and small molecules. Compared to current BBB shuttles, ExoPN-101 shows remarkable delivery efficiency and minimal immunogenic responses, making it a robust option for brain-targeted therapies. The safety of this platform has been confirmed through extensive non-human primate studies, which have sparked significant interest among multinational pharmaceutical companies.

LISCure's Expansion into Global Partnerships

This recent MTA marks a significant milestone as LISCure's fourth, affirming the technological advancement and market potential of the ExoPN-101 platform. The versatility of this technology allows LISCure to engage in multiple collaborations simultaneously, leading to ongoing discussions with several global pharmaceutical entities. By expanding its network, LISCure is positioning itself at the forefront of therapeutic innovation.

Recent Developments at the Bio-Europe 2025 Conference

At a recent Bio-Europe 2025 conference, LISCure had the opportunity to connect with various international partners to explore new collaborative efforts. Alongside discussions regarding the ExoPN-101 platform, the company advanced talks for LB-P8, a potential treatment for Primary Sclerosing Cholangitis (PSC), which has recently progressed to Phase 2 clinical trials.

Statements from Leadership

A spokesperson from LISCure emphasized the significance of the ExoPN-101 entering evaluation stages with multiple global partners, reinforcing the platform's credibility and readiness for more extensive applications. CEO Hwasup Chin highlighted the growing demand for BBB shuttle technologies, noting that ExoPN-101 addresses critical needs in the industry and expresses confidence in future partnerships and commercialization endeavors.

About LISCure Biosciences

LISCure Biosciences operates as a clinical-stage biotechnology company dedicated to crafting innovative therapeutics through advanced platform technologies. Their pipeline is not only limited to ExoPN-101, but also includes LB-P8, which features as a therapeutic candidate for PSC. LISCure aims to transform advanced scientific findings into practical therapies via strategic global collaborations.

Frequently Asked Questions

What is the significance of the ExoPN-101 platform?

The ExoPN-101 platform is pivotal for its ability to deliver various therapies directly into the brain, showing enhanced efficiency and safety compared to existing technologies.

How many MTAs have LISCure signed?

This is LISCure's fourth Material Transfer Agreement, indicating growing interest and validation in their technology from global partners.

What type of pharmaceutical collaborations does LISCure pursue?

LISCure seeks collaborations that not only validate their platforms but also enable joint development for wide-ranging therapeutic applications across different diseases.

Where did LISCure recently showcase its technology?

LISCure presented its advancements at the Bio-Europe 2025 conference, engaging with many international pharmaceutical companies.

What other candidates are in LISCure's pipeline?

Alongside ExoPN-101, LISCure is developing LB-P8, targeting therapeutic applications for Primary Sclerosing Cholangitis.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

$10,000 Boost Fuels Nichols College's Archaeological Quest

Updated Category News Views 178

Webster First's Generous Contribution It's not every day you see a credit union digging into history—literally. Webster First Federal Credit Union just dropped ten grand to fuel Nichols College's archaeological adventures. This isn't some trivial check to post on Instagram. No, we're talking about funding some serious ground-penetrating radar (GPR) gadgetry that's set...

Continue Reading
Palatin Prepares for FY27 Results Amid Market Curiosity

Updated Category News Views 149

Mark Your Calendars, Investors! Folks grumble about the mundane task of checking fiscal calendars, but without this intel, where are we? On November 17, 2026, Palatin Technologies (NASDAQ:PTN) is slated to release their Q1 Fiscal Year 2027 operating results bright and early, before most of us have even sipped our coffee. The buzz around these numbers is as electric as any...

Continue Reading
Understanding Septic Tank Pumping: Insights & Tips

Updated Category News Views 116

Why in the world are we discussing septic tanks today? Well, it’s because folks often overlook their importance until they’re knee-deep in unexpected plumbing woes. If you're a homeowner, understanding your septic system's needs is crucial to avoid literal and financial messes down the line. Behind the Scenes of Your Septic System Picture your household water usage....

Continue Reading
Anderson University Sees Financial Turnaround Success

Updated Category News Views 177

Anderson University, against all odds, is shaking up the financial narrative they’ve been stuck in for a while. It’s kind of like finding a $20 bill in an old coat—a nice surprise but it doesn’t happen every day. The university’s recent report on their financial progress is reminding folks that when it comes to fiscal discipline, sometimes you just need fresh...

Continue Reading
Dana-Farber Integrates IconPCR for Precise cfDNA Sequencing

Updated Category News Views 117

Innovating Precision in cfDNA Sequencing One day you're trudging along old paths, and the next, technology throws you a curveball that's too critical to ignore. That's the scene at Dana-Farber Cancer Institute with their latest lab upgrade. They've bent the knee to integrate n6's iconPCR system into their toolkit for liquid biopsy research—a move that's caught my...

Continue Reading
Bright Idea: Menu Covers Light Up Dining Spaces

Updated Category News Views 36

Lighting Up Dinner Conversations You ever sit in a restaurant dim enough to make you question if even the chef can see in that darkness? Enter the MENU AID, a nifty brainchild straight out of Chula Vista, California. This invention brings a bright twist to our dining escapades, literally. Picture a menu cover that lights up like it's got its own little halo, solving the...

Continue Reading
Procon Uses Robotics to Revamp Cruise Terminal 5

Updated Category News Views 58

Building Bigger with Robotics at Port Canaveral Robots on a construction site sounds like sci-fi, right? But it's the reality at Port Canaveral's Cruise Terminal 5, where Procon is rolling out its robotic tech magic. This ain't your everyday wrench-and-spanner job; we're talking remote-controlled bots capturing 360-degree images. “Regular reality capture can help teams...

Continue Reading
Etavopivat Aims to Tackle Sickle Cell Crisis Head-On

Updated Category News Views 176

Diving headfirst into the world of sickle cell disease, Novo Nordisk has just thrown its hat in the ring with etavopivat. Now, anyone who's been following the biotech dance knows this ain't no small feat. This investigational therapy is poised to shake things up, offering a new lifeline for those wrestling with this debilitating condition. And leaping from the Phase 3...

Continue Reading
Navigating Roof Damage Insurance Claims: Key Insights

Updated Category News Views 115

No one wants to deal with roof damage, but knowing the rules of the game is half the battle. The landscape of insurance claims can be tricky—especially when Mother Nature starts playing hard ball. Here, we break down what homeowners need to know to stay one step ahead in these situations. Unpacking Roof Damage Coverage Most homeowners think they've got things covered...

Continue Reading
CR&R Workers Join Teamsters, Fight for Fair Conditions

Updated Category News Views 74

Waste Workers Push Back Against Corporate Pressure The Southern California sun isn't the only thing heating up these days; the waste workers at CR&R Environmental Services have cranked up the heat by voting to join Teamsters Local 396. It's like Groundhog Day in the world of labor rights—same story, different locale, workers banding together for a fair shot. A Stand...

Continue Reading

Top 5 Most Recently Viewed Articles

Henning Cheese Excels with Top Awards at National Contest

Updated Category News Views 128

Henning Cheese Shines at the National Cheese Contest Henning Cheese has achieved remarkable recognition at the recent U.S. Championship Cheese Contest, where it secured multiple first-place awards and an impressive overall ranking. The company's standout entry, Onion & Chive Cheddar, once again placed within the top 20 overall, marking a significant achievement for the...

Continue Reading
Actelis Networks Introduces Innovative Cryptocurrency Strategy

Updated Category News Views 116

Actelis Networks Embraces Cryptocurrency for Treasury Management Actelis Networks, Inc. (NASDAQ: ASNS), based in Fremont, California, has taken an exciting step forward in its corporate strategy. The company, renowned for its market-leading cyber-hardened networking solutions for IoT and broadband applications, has announced an innovative treasury management strategy that...

Continue Reading
Nykredit Invest Balance Announces Trading Suspension with Key Details

Updated Category News Views 201

Nykredit Invest Balance Trading Suspension Nykredit Portefølje Administration A/S has made a significant decision by requesting Nasdaq Copenhagen to suspend trading in selected funds managed by their team. This step is essential as technical issues are currently preventing the correct calculation of the Net Asset Values (NAV) for these funds. Details of the Fund...

Continue Reading
European Wax Center Announces New Equity Grants for Employees

Updated Category News Views 179

Overview of European Wax Center's Inducement Grants European Wax Center, Inc. (NASDAQ: EWCZ), renowned for its exceptional out-of-home waxing services, has recently made a significant announcement regarding employee equity grants. This initiative aims to strengthen its position as a leading franchisor and operator in the industry. Effective from a noted date, the...

Continue Reading
Bread Financial Holdings: Navigating Challenges and Growth Ahead

Updated Category News Views 472

Understanding Bread Financial Holdings and Its Journey Bread Financial Holdings, Inc. (NYSE: BFH) is a significant entity in the U.S. consumer finance realm, facing a dynamic environment of regulatory obstacles and competitive landscapes. With an ongoing strategic shift, the company is attracting the attention of both analysts and investors as it seeks to carve a new path...

Continue Reading